OPENING OF BANKRUPTCY

ARTIALIS

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

-1,2 M €

+27.7% YoY

Gross margin

320,3 k €

+135.0% YoY

Equity

235,8 k €

-48.7% YoY

Workforce

13,6 ETP

-10.5% YoY

Company — Opening of bankruptcy.

What does ARTIALIS do?

ARTIALIS is a Public limited company incorporated in 2010. Its registered office is in Liège. It employs on average 13,6 ETP workers (FTE).

Legal situation

● Opening of bankruptcy

BCE/KBO no. / VAT

BE 0830.584.472

Incorporation

25/10/2010

Legal form

Public limited company

Registered office

Avenue Hippocrate 5
4000 Liège · WallonieSee on map

Contributed capital

1 805 737,22 €

Latest accounts

31/12/2024

Average workforce

13,6 ETP

Joint committees (2)

200
2000

Signals

Healthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 14 financial years

	2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011
Income statement
Gross margin	320,3 k €	+135%	136,3 k €	-90.0%	1,4 M €	-37.7%	2,2 M €	+2.9%	2,1 M €	+542%	330,8 k €	-78.1%	1,5 M €	+28.6%	1,2 M €	-29.6%	1,7 M €	+131%	722,5 k €	+32.9%	543,8 k €	+1.3%	536,6 k €	+337%	122,8 k €	+265%	-74,6 k €
EBITDA	-879,5 k €	+17.1%	-1,1 M €	-379%	379,7 k €	-60.3%	956,4 k €	-35.1%	1,5 M €	+212%	-1,3 M €	-334%	560,2 k €	+934%	-67,1 k €	-110%	673,1 k €	+833%	-91,9 k €	+60.7%	-233,8 k €	-2585%	9,4 k €	+106%	-155,9 k €	+64.1%	-434,9 k €
Operating result	-1,3 M €	+26.6%	-1,7 M €	-17499%	9,9 k €	-97.6%	419,1 k €	-57.1%	977,5 k €	+150%	-1,9 M €	-1075%	-164,7 k €	+72.6%	-601,9 k €	-321%	272,7 k €	+146%	-587,8 k €	+5.4%	-621,1 k €	-183%	-219,7 k €	+33.7%	-331,2 k €	+43.3%	-583,9 k €
Net result	-1,2 M €	+27.7%	-1,7 M €	-8041%	21,3 k €	-95.0%	429,8 k €	-52.2%	899,4 k €	+144%	-2,1 M €	-733%	-247,5 k €	+61.7%	-645,8 k €	-372%	237,9 k €	+144%	-546 k €	+17.2%	-659,4 k €	-176%	-238,9 k €	+27.3%	-328,7 k €	+42.4%	-570,2 k €
Balance sheet
Equity	235,8 k €	-48.7%	459,3 k €	-78.7%	2,2 M €	+1.0%	2,1 M €	+25.2%	1,7 M €	+238%	-1,2 M €	-248%	831,3 k €	-22.9%	1,1 M €	+5.6%	1 M €	+30.3%	783,8 k €	+13.6%	689,8 k €	+30.3%	529,2 k €	-31.1%	768,1 k €	-30.0%	1,1 M €
Total assets	1,7 M €	-20.8%	2,2 M €	-29.3%	3,1 M €	+4.8%	2,9 M €	+5.6%	2,8 M €	-19.2%	3,4 M €	-26.1%	4,6 M €	+22.2%	3,8 M €	+44.3%	2,6 M €	+12.9%	2,3 M €	-2.1%	2,4 M €	+39.7%	1,7 M €	+68.2%	1 M €	-14.1%	1,2 M €
Cash	99,1 k €	-4.1%	103,3 k €	+738%	12,3 k €	-97.6%	505 k €	+303%	125,4 k €	+852%	13,2 k €	-63.8%	36,4 k €	-74.0%	139,9 k €	+224%	43,2 k €	-54.5%	94,9 k €	-77.1%	414,6 k €	+80.9%	229,1 k €	+45.2%	157,8 k €	-65.4%	456,6 k €
Debts	1,5 M €	-13.3%	1,7 M €	+87.1%	910,6 k €	+17.3%	776,3 k €	-26.5%	1,1 M €	-76.7%	4,5 M €	+19.1%	3,8 M €	+47.7%	2,6 M €	+60.5%	1,6 M €	+7.7%	1,5 M €	-7.4%	1,6 M €	+38.1%	1,2 M €	+375%	245,3 k €	+197%	82,7 k €
Other
Workforce	13,6 ETP	-10.5%	15,2 ETP	+2.0%	14,9 ETP	+29.6%	11,5 ETP	+64.3%	7,0 ETP	-39.1%	11,5 ETP	-31.5%	16,8 ETP	-12.0%	19,1 ETP	+11.7%	17,1 ETP	+23.0%	13,9 ETP	+12.1%	12,4 ETP	+36.3%	9,1 ETP	+82.0%	5,0 ETP	0.0%	5,0 ETP

Governance

Board of directors

Seen on filing of 31/12/2024 · 3 active · 36 ended

Active mandates

Best Clinical Practice

Director · since 21 juin 2024 · until 21 juin 2030 · 0810.856.751

Represented by Van NIEUWENHOVE BENEDIKT

Active

NOSHAQ PARTNERS

Director · since 21 juin 2024 · until 21 juin 2030 · 0808.219.836

Represented by SABATEL HÉLÈNE

Active

VENTURE COACHING

Director · since 21 juin 2024 · until 21 juin 2030 · 0480.168.905

Represented by Nathalie Benoit

Active

Ended mandates

Dim3

Director · since 28 juin 2019 · until 08 mai 2025 · 0862.997.221

Represented by Jean-Claude HAVAUX

Ended

FleXXimum R & D

Director · since 28 juin 2019 · until 08 mai 2025 · 0826.583.916

Represented by Yves HEROTIN

Ended

FleXXimum R & D

Managing director · since 28 juin 2019 · until 08 mai 2025 · 0826.583.916

Represented by Yves HENROTIN

Ended

NOSHAQ

Director · since 28 juin 2019 · until 08 mai 2025 · 0426.624.509

Represented by Françoise LEBLANC

Ended

At this address

Other companies at this address

Company	CBE no.
Apmonia Therapeutics● Active	1026.581.583
BRENUS PHARMA BELGIUM● Active	1025.810.137
QUIDDITAS● Active	0794.472.362
Sagitta Biotech● Active	0724.569.610
Temple OrthoBiologics● Active	1012.358.316
XeroThera Europe● Active	0697.932.717

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	14/05/2025	06/08/2024	16/08/2023	31/08/2022	31/08/2021	30/10/2020
General meeting	22/04/2025	25/06/2024	11/05/2023	30/06/2022	02/06/2021	11/03/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

14 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2024	22/04/2025	14/05/2025	French	PDF
Abridged model	31/12/2023	25/06/2024	06/08/2024	French	PDF
Abridged model	31/12/2022	11/05/2023	16/08/2023	French	PDF
Abridged model	31/12/2021	30/06/2022	31/08/2022	French	PDF
Abridged model	31/12/2020	02/06/2021	31/08/2021	French	PDF
Abridged model	31/12/2019	11/03/2020	30/10/2020	French	PDF
Abridged model	31/12/2018	28/06/2019	29/07/2019	French	PDF
Abridged model	31/12/2017	05/06/2018	30/08/2018	French	PDF
Abridged model	31/12/2016	01/06/2017	20/07/2017	French	PDF
Abridged model	31/12/2015	30/05/2016	10/08/2016	French	PDF
Abridged model	31/12/2014	15/05/2015	05/08/2015	French	PDF
Abridged model	31/12/2013	15/05/2014	01/07/2014	French	PDF
Abridged model	31/12/2012	30/05/2013	30/07/2013	French	PDF
Abridged model	31/12/2011	07/06/2012	13/06/2012	French	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 3 active · 36 ended

Active mandates

Best Clinical Practice

Director · since 21 juin 2024 · until 21 juin 2030 · 0810.856.751

Represented by Van NIEUWENHOVE BENEDIKT

Active

NOSHAQ PARTNERS

Director · since 21 juin 2024 · until 21 juin 2030 · 0808.219.836

Represented by SABATEL HÉLÈNE

Active

VENTURE COACHING

Director · since 21 juin 2024 · until 21 juin 2030 · 0480.168.905

Represented by Nathalie Benoit

Active

Ended mandates

Dim3

Director · since 28 juin 2019 · until 08 mai 2025 · 0862.997.221

Represented by Jean-Claude HAVAUX

Ended

FleXXimum R & D

Director · since 28 juin 2019 · until 08 mai 2025 · 0826.583.916

Represented by Yves HEROTIN

Ended

FleXXimum R & D

Managing director · since 28 juin 2019 · until 08 mai 2025 · 0826.583.916

Represented by Yves HENROTIN

Ended

NOSHAQ

Director · since 28 juin 2019 · until 08 mai 2025 · 0426.624.509

Represented by Françoise LEBLANC

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates25/06/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Mandates20/10/2023
DEMISSIONS, NOMINATIONS
PDF
Registered office28/09/2023
SIEGE SOCIAL
PDF
Mandates20/09/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates14/07/2021
DEMISSIONS, NOMINATIONS
PDF
Capital / shares29/07/2020
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF
Mandates26/02/2020
DEMISSIONS, NOMINATIONS
PDF
Mandates29/11/2019
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 2024-1,2 M €↑
2023
Annual accounts 2023-1,7 M €↓
2022
Annual accounts 202221,3 k €↓
2021
Annual accounts 2021429,8 k €↓
2020
Annual accounts 2020899,4 k €↑
2019
Annual accounts 2019-2,1 M €↓
2018
Annual accounts 2018-247,5 k €↑
2017
Annual accounts 2017-645,8 k €↓
2016
Annual accounts 2016237,9 k €↑
2015
Annual accounts 2015-546 k €↑
2014
Annual accounts 2014-659,4 k €↓
2013
Annual accounts 2013-238,9 k €↑
2012
Annual accounts 2012-328,7 k €↑
2011
Annual accounts 2011-570,2 k €
25/10/2010
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

ARTIALIS

Overview

What does ARTIALIS do?

Trend over 14 financial years

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline